0001437749-17-014929.txt : 20170817
0001437749-17-014929.hdr.sgml : 20170817
20170817090323
ACCESSION NUMBER: 0001437749-17-014929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170816
FILED AS OF DATE: 20170817
DATE AS OF CHANGE: 20170817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASADORIAN RAFFI
CENTRAL INDEX KEY: 0001628970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 171037732
MAIL ADDRESS:
STREET 1: TBD
STREET 2: TBD
CITY: TBD
STATE: CA
ZIP: 99999
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
rdgdoc.xml
FORM 4 OPTIONS
X0306
4
2017-08-16
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001628970
ASADORIAN RAFFI
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
1
Chief Financial Officer
Stock Option (Right to Buy)
3
2017-08-16
4
A
0
220000
0
A
2018-08-16
2027-08-15
Common Stock
220000
220000
D
Issued pursuant to the 2011 Equity Incentive Plan.
The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (August 16, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
100% Acceleration upon Change of Control.
/s/ Martha Adler, Attorney-In-Fact
2017-08-17